L
Lineage Cell Therapeutics Inc
F:BT3
Lineage Cell Therapeutics Inc
F:BT3
Price:
1.024
EUR
0.39%
Market Cap:
€193.3m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Lineage Cell Therapeutics Inc
F:BT3
|
US |
|
Schneider Electric SE
OTC:SBGSF
|
FR |
|
Galaxy Digital Inc
NASDAQ:GLXY
|
US |
|
Duolingo Inc
NASDAQ:DUOL
|
US |
|
National Energy Services Reunited Corp
NASDAQ:NESR
|
US |
|
Charter Hall Long WALE REIT
ASX:CLW
|
AU |
|
Ducon Infratechnologies Ltd
NSE:DUCON
|
IN |
|
Atos SE
F:AXI0
|
FR |
|
D-Box Technologies Inc
TSX:DBO
|
CA |
|
E
|
Eversendai Corporation Bhd
KLSE:SENDAI
|
MY |
|
I
|
Insulet Corp
XBER:GOV
|
US |
|
Vivendi SE
PAR:VIV
|
FR |
|
A
|
Atlas Copco AB
DUS:ACO5
|
SE |
|
Eversource Energy
NYSE:ES
|
US |
|
Cogeco Inc
TSX:CGO
|
CA |
Multiples-Based Value
The Multiples-Based Value for Lineage Cell Therapeutics Inc (BT3) under the Base Case is hidden EUR. Compared with the current market price of 1.024 EUR, the stock appears hidden .
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
BT3 Multiples-Based Value
LOCKED
